Evaluation of Cyfra 21-1: A Potential Tumor Marker for Non-Small Cell Lung Carcinomas

Author： Karnak D.   Ulubay G.   Kayacan O.   Beder S.   İbis E.   Oflaz G.  

Publisher： Springer Publishing Company

ISSN： 0341-2040

Source： Lung, Vol.179, Iss.1, 2001-01, pp. : 57-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Is CEA Better than CYFRA 21-1 in the Monitoring of Squamous Cell Lung Cancer Progression?

By  

Medical Principles and Practice, Vol. 20, Iss. 2, 2011-01 ,pp. : 200-200

Karger

Access to resources Recommend Favorite

Taxanes in the Treatment of Non-Small Cell Lung Cancer

By Fanucchi Michael   Khuri Fadlo R.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 3, 2006-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite

TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells

By Mohammed Ahmed El Sayed   Eguchi Hidetaka   Wada Satoru   Koyama Nobuyuki   Shimizu Michio   Otani Keiko   Ohtaki Megu   Tanimoto Keiji   Hiyama Keiko   Gaber Mohammed Soliman   Nishiyama Masahiko  

Experimental Lung Research, Vol. 38, Iss. 9-10, 2012-11 ,pp. : 463-474

Informa Healthcare

Access to resources Recommend Favorite

A PROLIFERATION-INDUCING LIGAND: A NEW BIOMARKER FOR NON-SMALL CELL LUNG CANCER

By Sun Baolan   Wang Huimin   Wang Xing   Huang Hua   Ding Weifeng   Jing Rongrong   Shi Gongsheng   Zhu Li  

Experimental Lung Research, Vol. 35, Iss. 6, 2009-08 ,pp. : 486-500

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis in Non-Small Cell Lung Cancer: A New Target for Therapy

By Kim T.E.   Murren J.R.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 5, 2002-01 ,pp. : 325-338

Adis International

Access to resources Recommend Favorite